Skip to main content
Earnings Labs
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ·Healthcare·Biotechnology

$787.99

-0.16%

Mkt Cap $81.33B

Analyst Ratings

Buy

22

Hold

8

Sell

0

Price Target (145 analysts)

$827.71

Range $730.00$1,030.00

Implied Upside

+5.0%

Consensus $827.71 vs current $787.99